RSS

financing

Clinical stage drug development company, Forendo Pharma, has raised an additional €4 million of funding from Vesalius Biocapital III Partners, which will be used with other raised funds to accelerate the development of its women’s health portfolio. more

News

Privately held company, Emulate, has secured a $36 million Series C financing round, the funds from which will be used to expand the company’s product suite and commercialisation of its Human Emulation System. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

UK-based biotech, Orbit Discovery, has closed its series A financing round, raising £6.9 million, which will enable the company to expand its platform and achieve milestones in current partnerships. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Mimetas, provider of organ-on-a-chip technologies and tissue models, has secured $20.5 million in financing from an international syndicate from Asia and Europe. more

News

The BIA and business intelligence group, Informa, have released their first quarterly financing update on the biotech sector, showing that venture capital financing and follow on financings on the public markets are off to a solid start more

Analysis

The specialist Liverpool based chemical intermediates company, Liverpool Chirochem (LCC), has raised £1.5 million in equity finance to support growth plans and increase production capacity overseas. more

News

A financing round worth €38 million has been completed by biotech company, NMD Pharma, to advance the treatments of neuromuscular disorders. more

News

Cassini, developer of corneal diagnostic solutions, has successfully closed a series A financing round with venture capital fund Innovation Industries. more

Technology

Cambridge-based company, Evonetix, has completed a series A financing round, raising $12.3 million to be used in the advancement of its novel gene synthesis platform. more

News

Pandion Therapeutics, a biotechnology company, has raised $58 million at the completion of its Series A financing round, which will be used to advance its initial drug programmes for autoimmune and inflammatory diseases more

News

Biotech company Scholar Rock has closed a $47 million Series C financing round, which will be used to advance its innovative pipeline for spinal muscular atrophy (SMA), immune-oncology, fibrosis and iron-restricted anaemias. more

News

Software company that specialises in applications for life sciences research, Discngine, has raised €1.1 million in a Series A financing round, allowing the company to move forward with its Software-as-a-Service (SaaS) solution. more

Technology

NorthSea Therapeutics, a Dutch biotech company, has secured €25 million in a Series A funding round, which will be used for the development of icosabutate — a SEFA as a novel, oral approach for the treatment of NASH more

News

Biopharmaceutical company, Antabio, has completed a €7.3 million series A financing round for the development of novel therapies to treat drug-resistant gram-negative infections. more

News

Chris Wilkinson, head of sales for Healthcare for Siemens Financial Services in the UK, looks at the value of new-generation digitalised technology within the pharmaceutical industry. more

Opinion

Chris Wilkinson, head of sales for Healthcare and Public Sector for Siemens Financial Services, UK, writes about the importance for pharma to keep up with technological advancements and how flexible financing can help. more

Opinion

Clinical-stage Swiss speciality pharma company, Polyphor, has announced the completion of a CHF40 million private placement. The majority of the financing (98%) was provided by existing investors. more

News

Thermo Fisher Scientific has bought Affymetrix, a provider of cellular and genetic analysis products for £898m ($1.3bn) more

News